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Microvascular endothelial dysfunction is associated
with albuminuria: theMaastricht Study
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Pieter C. Dagnelied,f,g, Carla J.H. van der Kallenc,d, Abraham A. Kroonc,d, Karel M.L. Leunissena,b,
Frank M. van der Sandea, Nicolaas C. Schaperc,d,f, Jan S.A.G. Schoutene, Miranda T. Schramc,d,h,
Simone J.S. Sepc,d, Ben M. Sörensenc,d, Ronald M.A. Henryc,d,h, and Coen D.A. Stehouwerc,d
See editorial comment on page 1036
Objective: Albuminuria is thought to be a biomarker of
microvascular and macrovascular endothelial dysfunction.
However, direct evidence for an association of microvascular
endothelial dysfunction with albuminuria is limited. In
addition, experimental data suggest a stronger association
of microvascular endothelial dysfunction with albuminuria in
individuals with than in those without diabetes.
Methods: We examined cross-sectional associations of
flicker light-induced retinal arteriolar dilation (n¼2095)
and heat-induced skin hyperemia (n¼ 1508) with 24-h
albuminuria in the population-based, diabetes-enriched
Maastricht Study. We used linear regression analyses to
adjust for age, sex, type 2 diabetes, and cardiovascular
disease risk factors. In addition, we tested for statistical
interaction with type 2 diabetes.
Results: Median [interquartile range] albuminuria was 6.5
[3.9–11.6] mg/24 h and 8.2% had albuminuria at least
30 mg/24 h. After adjustment, albuminuria was 1.168
(95% confidence interval, 1.046–1.303) times greater in
participants in the quartile with the smallest flicker light-
induced retinal arteriolar dilation relative to those with the
greatest dilation, and this association was stronger in
participants with type 2 diabetes (Pinteraction<0.10).
Further, each 100 percentage points lower heat-induced
skin hyperemia was associated with a 1.022 (1.010–1.035)
times greater albuminuria in participants with type 2
diabetes, whereas it was not associated with albuminuria
in nondiabetic participants (Pinteraction<0.10).
Conclusion: This is the first population-based study that
provides direct evidence that microvascular endothelial
dysfunction is associated with albuminuria, and that this
association is stronger in individuals with than in those
without type 2 diabetes.
Keywords: albuminuria, cardiovascular disease, diabetes
mellitus, endothelial dysfunction, endothelium,
microalbuminuria, microcirculation
Abbreviations: CKD-EPI, Chronic Kidney Disease
Epidemiology Collaboration; CVD, cardiovascular disease;
DVA, dynamic vessel analyzer; eGFR, estimated glomerular
filtration rate; HbA1c, hemoglobin A1c; NO, nitric oxide;
Q, quartile; UAE, urinary albumin excretion; VEGF, vascular
endothelial growth factor
INTRODUCTION
A
lbuminuria is a marker of risk of not only renal
failure and cardiovascular disease (CVD) [1], but
also of retinopathy [2], heart failure [3], impaired
cognitive performance [4], and depression [5]. A leading
hypothesis to explain these associations is that albuminuria
is a biomarker of generalized (i.e. microvascular and macro-
vascular) endothelial dysfunction [2,5–8].
This concept posits that endothelial dysfunction of renal
arterioles and capillaries (i.e. the renal microcirculation)
increases intraglomerular pressure and glomerular capillary
wall permeability, and thereby causes albuminuria [6].
Concomitantly, endothelial dysfunction of the extrarenal
microcirculation contributes to retinopathy, cognitive
decline, depression, and heart failure with preserved ejec-
tion fraction [2,5,7,8], whilst endothelial dysfunction in
coronary and carotid arteries (i.e. the macrocirculation)
leads to atherothrombotic CVD [6].
Indeed, there is strong evidence for the presence of
endothelial dysfunction in the macrocirculation of individ-
uals with albuminuria [9–11].
In contrast, evidence for endothelial dysfunction in the
microcirculation of individuals with albuminuria is primar-
ily indirect. It derives mainly from studies using plasma
biomarkers [12–14] and the transcapillary escape rate of
albumin [15,16]. In addition, for individuals with diabetes
only, support comes from studies using strain-gauge
plethysmography following forearm ischemia [17], and
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laser Doppler flowmetry following either iontophoresis of
acetylcholine and sodium nitroprusside [18], or arterial
occlusion [19].
Importantly, experimental data suggest that the associa-
tion of microvascular endothelial dysfunction with albu-
minuria may be stronger in individuals with diabetes than in
nondiabetic individuals [20,21].
In view of the above, we examined, in a population-
based cohort study of individuals without and with type 2
diabetes, whether direct measures of microvascular endo-
thelial dysfunction are associated with albuminuria. For this
purpose, we assessed flicker light-induced retinal arteriolar
dilation and heat-induced skin hyperemia. These responses
are thought to involve the endothelial release of NO as well
as other vasodilators [22,23], and can be assessed noninva-
sively [22,23] and reproducibly [24,25] with the Dynamic
Vessel Analyzer (DVA) [22] and laser Doppler flowmetry
[23], respectively. Notwithstanding these similarities, both
methods provide information on different vessel types and
allow testing of vessel-reactivity to different stimuli and
of different vessel responses. In addition, we examined
whether any association of microvascular endothelial dys-
function with albuminuria is stronger in individuals with
type 2 diabetes than in those without.
RESEARCH DESIGNANDMETHODS
The Maastricht Study population and design
We used data from the Maastricht Study, an observational
prospective population-based cohort study. The rationale
and methodology have been described previously [26]. In
brief, the study focuses on the etiology, pathophysiology,
complications and comorbidities of type 2 diabetes, and is
characterized by an extensive phenotyping approach.
Eligible for participation were all individuals aged between
40 and 75 years and living in the southern part of the
Netherlands. Participants were recruited through mass
media campaigns and from the municipal registries and
the regional Diabetes Patient Registry via mailings. Recruit-
ment was stratified according to known type 2 diabetes
status, with an oversampling of individuals with type 2
diabetes, for reasons of efficiency. The present report
includes cross-sectional data from the first 3451 partici-
pants, who completed the baseline survey between
November 2010 and September 2013. The examinations
of each participant were performed within a time window
of 3 months. The study has been approved by the institu-
tional medical ethical committee (NL31329.068.10) and the
Minister of Health, Welfare and Sports of the Netherlands
(Permit 131088-105234-PG), and was conducted in accor-
dance with the Declaration of Helsinki. All participants gave
written informed consent.
Assessment of microvascular endothelial
function
All participants were requested to refrain from smoking and
drinking caffeine-containing beverages 3 h before the
measurements. A light meal (breakfast and/or lunch) low
in fat content was allowed at least 90min before the start of
the measurements [27].
Flicker light-induced retinal arteriolar dilation
The retinal arteriolar response to flicker light was assessed
with the DVA (Imedos, Jena, Germany) as described pre-
viously [27]. Briefly, pupils were dilated with 0.5% tropi-
camide and 2.5% phenylephrine at least 15 min prior to the
start of the examination. For safety reasons, participants
with an intraocular pressure more than 30 mmHg were
excluded from the measurements. Per participant, either
the left or right eye was selected depending on the time
of day the measurement was performed and without
reference to participant characteristics. A straight arteriolar
segment of approximately 1.5 mm in length located
0.5–2 disc diameter from the margin of the optic disc in
the temporal section was examined. Vessel diameter was
automatically and continuously measured for 150 s. A
baseline recording of 50 s was followed by a 40-s flicker
light exposure period (flicker frequency 12.5 Hz, bright-to-
dark contrast ratio 25 : 1), followed by a 60-s recovery
period. Baseline retinal arteriolar diameter and flicker
light-induced retinal arteriolar dilation were automatically
calculated with the integrated DVA software (version 4.51;
Imedos, Jena, Germany). Baseline retinal arteriolar diame-
ter was calculated as the average diameter of the 20–50 s
recording and was expressed in measurement units, where
one measurement unit is equal to 1 mm of the Gullstrand
eye. Flicker light-induced retinal arteriolar dilation was
expressed as the percentage retinal arteriolar dilation over
baseline and based on the average dilation achieved at
time-points 10 and 40 s during the flicker stimulation
period.
Heat-induced skin hyperemia
Heat-induced skin hyperemia was assessed with a laser
Doppler system (Periflux 5000; Perimed, Stockholm,
Sweden), equipped with a thermostatic laser Doppler
probe (PF457; Perimed) at the dorsal side of the wrist of
the left hand, as described previously [27]. Briefly, skin
blood flow measurements were performed in a climate-
controlled room at 24 8C. The laser Doppler output was
recorded for 25 min with a sample rate of 32 Hz, which
gives semi-quantitative assessment of skin blood flow
expressed in arbitrary perfusion units. Skin blood flow
was first recorded unheated for 2 min to serve as a baseline.
Thereafter, the temperature of the probe was rapidly
and locally increased to 44 8C, and then kept constant
until the end of the registration. In 596 individuals, heat-
induced skin hyperemia measurements were recorded
between 20 and 25 min. These data were extrapolated to
25 min by adding the product of the average arbitrary
perfusion units during the last completely recorded
1-min interval and a correction factor of 1.017, to the
average arbitrary perfusion units during the recorded time,
and taking the recording time into account. The correction
factor of 1.017 was the ratio of the average arbitrary
perfusion units in the 20–25 min interval (based on all
available data) relative to the 19–20 min interval. The heat-
induced skin hyperemic response was expressed as the
percentage increase in average arbitrary perfusion units
during the 23 min heating phase over the average baseline
arbitrary perfusion units.
Microvascular endothelium and albuminuria
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Albuminuria
To assess urinary albumin excretion (UAE), participants
were requested to collect two 24-h urine collections (Sup-
plemental Methods, http://links.lww.com/HJH/A898).
UAE was expressed both as a continuous and as a cate-
gorical variable (<15mg/24 h, 15 to <30mg/24 h, and
30mg/24 h), in agreement with the fact that an association
with (cardiovascular) disease already exists below the
clinical cut-off value of 30mg/24 h [1]. These definitions
were preferably based on the average of two (available in
91.5% of the participants) 24-h urine collections.
Potential confounders
We assessed fasting glucose, hemoglobin A1c (HbA1c),
glucose metabolism status, total cholesterol, high-density
lipoprotein (HDL) cholesterol, low-density lipoprotein
(LDL) cholesterol, triglycerides, BMI, waist circumference,
office blood pressure, 24-h average ambulatory blood
pressure, medication use, smoking behavior, alcohol con-
sumption, educational level, prevalent CVD, and self-
reported physical activity, as described previously [26].
Glomerular filtration rate (GFR) was estimated with the
Chronic Kidney Disease Epidemiology Collaboration
(CKD-EPI) equation based on both serum creatinine and
serum cystatin C (eGFRcrcys) [28]. Further details on the
definitions of the above potential confounders are provided
in the Supplemental Methods, http://links.lww.com/HJH/
A898. In addition, we assessed the retinopathy status as
described in the Supplemental Methods, http://links.lww.
com/HJH/A898.
Statistical analyses
All analyses were performed with IBM SPSS Statistics Ver-
sion 22.0 (IBM Corp, Armonk, New York, USA) in the
population with complete data on all variables used in
the fully adjusted model. Characteristics of the entire study
population and according to albuminuria categories were
summarized as means with standard deviations (SD),
medians with interquartile ranges, and numbers with per-
centages, as appropriate.
The correlation between flicker light-induced retinal
arteriolar dilation and heat-induced skin hyperemia was
assessed with a Pearson correlation coefficient.
Baseline retinal arteriolar diameter and flicker light-
induced retinal arteriolar dilation were categorized into
quartiles as the associations of flicker light-induced retinal
arteriolar dilation with albuminuria seemed to be nonlinear.
The quartile with the largest baseline retinal arteriolar
diameter and the quartile with the greatest flicker light-
induced retinal arteriolar dilation served as reference cate-
gories. Baseline skin perfusion and heat-induced skin
hyperemia were analyzed as continuous variables and
expressed per one arbitrary perfusion unit lower baseline
skin perfusion and per 100 percentage points lower heat-
induced skin hyperemia, respectively.
Associations of baseline retinal arteriolar diameter,
flicker light-induced retinal arteriolar dilation, baseline skin
perfusion, and heat-induced skin hyperemia with UAE,
expressed as a continuous variable, were examined with
multivariable linear regression analyses. UAE was highly
positively skewed and had to be transformed by taking the
inverse square root to fulfill the normality assumption of
linear regression. However, as the results obtained with
natural logarithm transformed UAE were qualitatively simi-
lar and are more easily interpretable, these results are
presented. The regression coefficients were exponentiated
to obtain the ratio of UAE per one unit increase in the
independent variable. In addition, we performed multino-
mial logistic regression analyses to examine the associations
with UAE expressed as a categorical dependent variable
(<15mg/24 h served as the reference category). All analy-
ses were adjusted for potential confounders as follows:
model 1, unadjusted model; model 2, age, sex, glucose
metabolism status; model 3a, model 2 combined with waist
circumference, total-to-HDL cholesterol ratio, triglycerides,
use of lipid-modifying medication, office SBP, use of anti-
hypertensive medication (including renin–angiotensin
system inhibitors), eGFRcrcys, prevalent CVD, smoking
behavior, alcohol consumption, educational level; model
3b, as model 3a but adjusted for 24-h average ambulatory
SBP instead of office SBP.
In addition, we tested for statistical interaction with type
2 diabetes (Pinteraction< 0.10 was considered statistically
significant). In these analyses, participants with normal
glucose metabolism and prediabetes (Supplemental
Methods, http://links.lww.com/HJH/A898) were combined
into one category, because of the small number of partic-
ipants with prediabetes and the even smaller number of
participants in the respective albuminuria categories in
this group.
We performed several additional analyses, each starting
from model 3a. First, we tested for statistical interaction with
HbA1c and eGFR to explore whether hyperglycemia and
glomerular hyperfiltration [29,30], respectively, modified
our results. Second, we performed several analyses to
assess the robustness of our results. These are described
in the Supplemental Methods, http://links.lww.com/HJH/
A898.
RESULTS
Characteristics of the study population
Supplemental Figure 1, http://links.lww.com/HJH/A898
is a flow diagram delineating the derivation of the final
study populations. In total, 2095 participants were included
in the analyses on flicker light-induced retinal arteriolar
dilation (retina study population) and 1508 in the analyses
on heat-induced skin hyperemia (skin study population).
None of the participants was on dialysis. The characteristics
shown in Table 1 of included versus excluded participants
because of missing data were largely comparable (data not
shown).
Table 1 and Supplemental Table 1, http://links.lww.
com/HJH/A898 present the characteristics of the retina
and skin study populations, respectively, according to
albuminuria categories. The characteristics of both study
populations were similar. In general, participants with
higher UAE were older and more often men; more often
had type 2 diabetes, hypertension and retinopathy; had a
lower eGFR based on both serum creatinine and serum
cystatin C (eGFRcrcys) and a worse CVD risk profile; and
Martens et al.
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TABLE 1. Characteristics of the retina study population stratified according to albuminuria categories
Entire population Less than 5 mg/24 h 15 to less than 30 mg/24 h At least 30 mg/24 h
Characteristic (n¼2095) (n¼1707) (n¼216) (n¼172)
Demographics
Age (years) 59.78.3 59.18.2 61.78.4 63.37.6
Men 1075 (51.3%) 824 (48.3%) 129 (59.7%) 122 (70.9%)
Educational level
Low 332 (15.8%) 247 (14.5%) 36 (16.7%) 49 (28.5%)
Middle 898 (42.9%) 745 (43.6%) 93 (43.1%) 60 (34.9%)
High 865 (41.3%) 715 (41.9%) 87 (40.3%) 63 (36.6%)
Prior cardiovascular disease 328 (15.7%) 239 (14.0%) 39 (18.1%) 50 (29.1%)
Lifestyle variables
Smoking behaviour
Never smoker 737 (35.2%) 630 (36.9%) 64 (29.6%) 43 (25.0%)
Former smoker 1104 (52.7%) 881 (51.6%) 126 (58.3%) 97 (56.4%)
Current smoker 254 (12.1%) 196 (11.5%) 26 (12.0%) 32 (18.6%)
Alcohol consumption
None 377 (18.0%) 294 (17.2%) 36 (16.7%) 47 (27.3%)
Low (women, 7 glasses/week;
men, 14 glasses/week)
1188 (56.7%) 979 (57.4%) 124 (57.4%) 85 (49.4%)
High (women >7 glasses/week;
men >14 glasses/week)
530 (25.3%) 434 (25.4%) 56 (25.9%) 40 (23.3%)
Metabolic variables
BMI categoriesa
Normal weight (<25 kg/m2) 759 (36.2%) 674 (39.5%) 52 (24.1%) 33 (19.2%)
Overweight (25 to <30 kg/m2) 890 (42.5%) 714 (41.9%) 104 (48.1%) 72 (41.9%)
Obesity (30 kg/m2) 445 (21.3%) 318 (18.6%) 60 (27.8%) 67 (39.0%)
Waist circumference (cm)
Men 101.111.8 99.711.3 104.410.7 106.813.8
Women 89.312.6 88.512.0 91.814.6 97.715.2
Office SBP (mmHg) 135.018.0 133.317.4 140.417.7 144.619.7
Office DBP (mmHg) 76.49.9 76.09.8 77.810.6 78.09.6
24-h average ambulatory SBP (mmHg)a 119.111.6 117.810.9 123.511.9 126.713.2
24-h average ambulatory DBP (mmHg)a 73.57.2 73.27.0 75.18.4 74.87.4
Hypertension 1166 (55.7%) 871 (51.0%) 151 (69.9%) 144 (83.7%)
Glucose metabolism status
Normal glucose metabolism 1197 (57.1%) 1053 (61.7%) 91 (42.1%) 53 (30.8%)
Impaired fasting glucose 85 (4.1%) 70 (4.1%) 10 (4.6%) 5 (2.9%)
Impaired glucose tolerance 239 (11.4%) 206 (12.1%) 20 (9.3%) 13 (7.6%)
Type 2 diabetes 574 (27.4%) 378 (22.1%) 95 (44.0%) 101 (58.7%)
Fasting glucose (mmol/l)
Without type 2 diabetes 5.30.5 5.30.5 5.40.6 5.50.6
With type 2 diabetes 8.02.1 7.81.9 7.92.2 8.62.6
HbA1C (%)a
Without type 2 diabetes 5.50.4 5.50.4 5.50.4 5.50.3
With type 2 diabetes 6.91.1 6.80.9 6.91.1 7.31.4
Total cholesterol (mmol/l) 5.21.2 5.31.2 5.01.2 4.81.2
HDL cholesterol (mmol/l)
Men 1.30.4 1.40.4 1.30.3 1.30.4
Women 1.80.5 1.80.5 1.70.5 1.60.5
LDL cholesterol (mmol/l) 3.11.0 3.11.0 2.91.0 2.61.1
Triglycerides (mmol/l) 1.22 [0.88–1.72] 1.18 [0.86–1.66] 1.31 [0.97–1.90] 1.49 [1.10–2.23]
Total-to-HDL cholesterol ratio 3.61.2 3.61.2 3.71.2 3.71.1
Kidney function
eGFR (ml/min per 1.73 m2) 88.314.7 89.113.8 87.016.4 81.818.1
Urinary albumin excretion (mg/24 h) 6.5 [3.9–11.6] 5.4 [3.6–8.1] 19.3 [16.4–23.4] 62.3 [40.5–109.6]
Urinary albumin excretion categories
<15 mg/24 h 1707 (81.5%) – – –
15 to <30 mg/24 h 216 (10.3%) – – –
30 mg/24 h 172 (8.2%) – – –
Medication
Antihypertensive medication (including
renin–angiotensin system inhibitors)
806 (38.5%) 587 (34.4%) 101 (46.8%) 118 (68.6%)
Renin–angiotensin system inhibitor 604 (28.8%) 424 (24.8%) 80 (37.0%) 100 (58.1%)
Lipid-modifying medication 737 (35.2%) 541 (31.7%) 94 (43.5%) 102 (59.3%)
Microvascular measurements
Retinopathya 27 (1.3%) 16 (1.0%) 6 (3.0%) 5 (3.0%)
Baseline retinal arteriolar diameter
(measurement units)
115.515.6 115.615.7 115.516.0 115.114.5
Mean percentage arteriolar dilatation (%) 2.6 [0.8–5.0] 2.8 [0.9–5.2] 1.9 [0.6–3.8] 1.4 [0.4–4.0]
Microvascular endothelium and albuminuria
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more often used antihypertensive and lipid-modifying
medication.
Flicker light-induced retinal arteriolar dilation
and heat-induced skin hyperemia
The Pearson correlation coefficient between retinal arteri-
olar dilation and heat-induced skin hyperemia was 0.05
(P¼ 0.121).
Flicker light-induced retinal arteriolar dilation
and albuminuria
Flicker light-induced retinal arteriolar dilation was catego-
rized into quartiles as its association with albuminuria
seemed to be nonlinear. Quartile (Q) 1 consisted of the
participants with the greatest flicker light-induced retinal
arteriolar dilation and served as the reference category. In
the entire retina study population and with UAE expressed
as a continuous variable, UAE was higher in Q2 (albeit
not statistically significantly), was statistically significantly
higher in Q3 and then showed no further increase in
Q4, after adjustment for potential confounders (Table 2,
model 3a). For example, UAE was [ratio (95% confidence
interval: 95% CI)] 1.099 (0.987–1.224) times higher in
Q2, 1.189 (1.067–1.326) times higher in Q3, and 1.168
(1.046–1.303) times higher in Q4. Results were similar
whenever we replaced office SBP with 24-h average ambu-
latory SBP (n¼ 1856; Table 2, model 3b) and whenever
UAE was expressed as a categorical variable (Supplemental
Table 2, http://links.lww.com/HJH/A898).
Analyses with interaction terms suggested that the asso-
ciation of flicker light-induced retinal arteriolar dilation
with albuminuria was stronger in participants with type 2
diabetes than without type 2 diabetes (P value of the
interaction term (Pinteraction)< 0.10 for the associations of
Q3 and Q4 with UAE expressed as a continuous variable,
and for the association of Q3 with UAE 30mg/24 h;
Table 2 and Supplemental Table 2, http://links.lww.com/
HJH/A898, model 3a; also illustrated in Fig. 1a). However,
the stratified analyses were hampered by a loss of statistical
power.
Baseline retinal arteriolar diameter was not associated
with continuous or categorical UAE (Supplemental Tables 3
and 4, http://links.lww.com/HJH/A898, models 1–3),
regardless of type 2 diabetes (Pinteraction> 0.10).
Heat-induced skin hyperemia and albuminuria
In the entire skin study population, heat-induced skin
hyperemia was not associated with UAE, expressed as
TABLE 1 (Continued)
Entire population Less than 5 mg/24 h 15 to less than 30 mg/24 h At least 30 mg/24 h
Characteristic (n¼2095) (n¼1707) (n¼216) (n¼172)
Baseline skin perfusion (perfusion units)a 9.3 [7.1–13.1] 9.2 [7.0–12.8] 9.5 [7.4–14.9] 9.2 [7.4–13.4]
Heat-induced skin hyperemia (%)a 998.5 [588.5–1507.2] 1028.3 [613.5–1515.4] 878.4 [457.4–1502.5] 785.3 [468.4–1137.3]
Data are presented as n (%), mean SD, or median [interquartile range].
eGFR, estimated glomerular filtration rate; HbA1c, hemoglobin A1c (glycated hemoglobin); HDL cholesterol, high-density lipoprotein cholesterol; LDL cholesterol, low-density lipoprotein
cholesterol
aData were available in n¼2094 (BMI categories), n¼1856 (24-h average ambulatory blood pressure), n¼2093 (HbA1c), n¼2031 (retinopathy), n¼1105 (baseline skin perfusion and
heat-induced skin hyperemia).
TABLE 2. Associations of flicker light-induced retinal arteriolar dilation with urinary albumin excretion expressed as a continuous variable
Entire retina study
population
Without type
2 diabetes
With type
2 diabetes
Model Ratio (95% CI) P value Ratio (95% CI) P value Ratio (95% CI) P value Pinteraction
1 Q1 Reference Reference Reference
Q2 1.110 (0.989; 1.245) 0.075 1.037 (0.915; 1.174) 0.575 1.302 (1.020; 1.664) 0.034 0.102
Q3 1.306 (1.164; 1.465) <0.001 1.120 (0.985; 1.271) 0.084 1.649 (1.307; 2.079) <0.001 0.004
Q4 1.370 (1.221; 1.537) <0.001 1.154 (1.011; 1.317) 0.033 1.536 (1.229; 1.919) <0.001 0.031
2 Q1 Reference Reference Reference
Q2 1.091 (0.977; 1.217) 0.122 1.052 (0.931; 1.190) 0.415 1.292 (1.014; 1.644) 0.038 0.140
Q3 1.203 (1.077; 1.343) 0.001 1.111 (0.978; 1.260) 0.105 1.584 (1.259; 1.994) <0.001 0.008
Q4 1.179 (1.054; 1.318) 0.004 1.115 (0.978; 1.271) 0.103 1.458 (1.170; 1.818) 0.001 0.040
3a Q1 Reference Reference Reference
Q2 1.099 (0.987; 1.224) 0.086 1.062 (0.941; 1.198) 0.331 1.279 (1.008; 1.623) 0.043 0.170
Q3 1.189 (1.067; 1.326) 0.002 1.106 (0.976; 1.252) 0.112 1.520 (1.214; 1.906) <0.001 0.015
Q4 1.168 (1.046; 1.303) 0.006 1.117 (0.982; 1.271) 0.092 1.387 (1.116; 1.724) 0.003 0.092
3b Q1 Reference Reference Reference
Q2 1.116 (0.998; 1.247) 0.054 1.066 (0.941; 1.208) 0.317 1.340 (1.050; 1.713) 0.019 0.102
Q3 1.153 (1.029; 1.289) 0.013 1.084 (0.953; 1.234) 0.216 1.436 (1.137; 1.813) 0.002 0.039
Q4 1.147 (1.024; 1.285) 0.018 1.100 (0.963; 1.256) 0.159 1.350 (1.079; 1.690) 0.009 0.123
Ratios represent the ratio of urinary albumin excretion in the respective quartile of flicker light-induced retinal arteriolar dilation compared with the reference quartile. Model 1:
unadjusted model; model 2: age, sex, glucose metabolism status (for ‘entire retina study population’ only); model 3a: model 2 combined with waist circumference, total-to-high-density
lipoprotein cholesterol ratio, triglycerides, use of lipid-modifying drugs, office SBP, use of antihypertensive medication, estimated glomerular filtration rate, prevalent cardiovascular
disease, smoking behavior, alcohol consumption, educational level; model 3b: as model 3a but adjusted for 24-h average ambulatory SBP instead of office SBP (n¼1856). CI, confidence
interval; Q, quartile.
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either a continuous or a categorical variable, after adjust-
ment for potential confounders (Table 3 and Supplemental
Table 5, http://links.lww.com/HJH/A898, model 3a). How-
ever, analyses with interaction terms suggested statistical
interaction with type 2 diabetes (Pinteraction< 0.10), to such
an extent that lower heat-induced skin hyperemia was
associated with higher UAE, expressed as a continuous
variable, in participants with type 2 diabetes but not in
those without type 2 diabetes (Table 3, models 1–3; also
illustrated in Fig. 1b). For example, after adjustment for
potential confounders and in participants with type 2
diabetes, each 100 percentage points lower heat-induced
skin hyperemia was associated with a [Ratio (95% CI)] 1.022
(1.010–1.035) times higher UAE (Table 3, model 3a).
Results were similar whenever we replaced office SBP with
24-h average ambulatory SBP (n¼ 1324; Table 3, model 3b)
and whenever UAE was expressed as a categorical variable
(Supplemental Table 5, http://links.lww.com/HJH/A898).
In the entire skin study population, baseline skin perfu-
sion was associated with UAE expressed as a categorical
variable, but not with UAE expressed as a continuous vari-
able (Supplemental Tables 6 and 7, http://links.lww.com/
(a) (b)
(c) (d)
FIGURE 1 Flicker light-induced retinal arteriolar dilation and heat-induced skin hyperemia are associated with albuminuria. Panels a and b present the associations of flicker
light-induced retinal arteriolar dilation and heat-induced skin hyperemia, respectively, with albuminuria, and the interaction with type 2 diabetes. Panels c and d present
the interaction of flicker light-induced retinal arteriolar dilation and heat-induced skin hyperemia, respectively, with HbA1c. Ratios indicate the ratio of geometric mean
urinary albumin excretion relative to participants in the quartile with the greatest flicker light-induced retinal arteriolar dilation and per 100 percentage points lower heat-
induced skin hyperemia, respectively. For heat-induced skin hyperemia, the median heat-induced skin hyperemia (998%) served as the reference. All results are adjusted
for the variables of model 3a (see text). Bars and dashed lines indicate 95% confidence intervals. ref, reference; HbA1c, hemoglobin A1c (glycated hemoglobin); UAE,
urinary albumin excretion.
TABLE 3. Associations of heat-induced skin hyperemia with urinary albumin excretion expressed as a continuous variable
Entire skin study population Without type 2 diabetes With type 2 diabetes
Model Ratio (95% CI) P value Ratio (95% CI) P value Ratio (95% CI) P value Pinteraction
1 1.013 (1.007; 1.019) <0.001 1.001 (0.994; 1.008) 0.839 1.027 (1.015; 1.040) <0.001 <0.001
2 1.004 (0.998; 1.010) 0.217 0.997 (0.990; 1.004) 0.447 1.024 (1.012; 1.037) <0.001 <0.001
3a 1.003 (0.997; 1.009) 0.264 0.997 (0.991; 1.004) 0.467 1.022 (1.010; 1.035) <0.001 <0.001
3b 1.002 (0.996; 1.008) 0.590 0.996 (0.989; 1.003) 0.287 1.019 (1.007; 1.031) 0.002 0.001
Ratios represent the ratio of urinary albumin excretion per 100 percentage points lower heat-induced skin hyperemia. Model 1: unadjusted model; model 2: age, sex, glucose
metabolism status (for ‘entire skin study population’ only); model 3a: model 2 combined with waist circumference, total-to-high-density lipoprotein cholesterol ratio, triglycerides, use of
lipid-modifying drugs, office SBP, use of antihypertensive medication, estimated glomerular filtration rate, prevalent cardiovascular disease, smoking behavior, alcohol consumption,
educational level; model 3b: as model 3a but adjusted for 24-h average ambulatory SBP instead of office SBP (n¼ 1324). CI, confidence interval.
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HJH/A898, models 1–3). Analyses with interaction terms
suggested that the association with UAE expressed as a
continuous variable was stronger in participants with type
2 diabetes (Pinteraction¼ 0.10), although this was not clear for
UAE expressed as a categorical variable (Supplemental
Tables 6 and 7, http://links.lww.com/HJH/A898).
Additional analyses
First, we explored whether hyperglycemia and glomerular
hyperfiltration [29,30] could explain why the associations of
flicker light-induced retinal arteriolar dilation and heat-
induced skin hyperemia with albuminuria were more evi-
dent in participants with type 2 diabetes. Therefore, we
additionally tested for statistical interaction between both
measures of microvascular endothelial dysfunction and
hemoglobin A1c (HbA1c; glycated hemoglobin) as well
as eGFR in model 3a. These analyses indicated that flicker
light-induced retinal arteriolar dilation and heat-induced
skin hyperemia were more strongly associated with albu-
minuria at higher HbA1c levels (Pinteraction< 0.10; illustrated
in Fig. 1c and d), but not at higher eGFR (data not shown).
Thus, for Q2, Q3, and Q4 of flicker light-induced retinal
arteriolar dilation, the ratio of UAE relative to Q1 was 1.106
(P¼ 0.186), 1.162 (P¼ 0.035), and 1.147 (P¼ 0.052) times
higher, respectively, per one percentage point higher
HbA1c. In addition, the ratio of UAE per 100 percentage
points lower heat-induced skin hyperemia was 1.013
(P¼ 0.002) times higher per one percentage point higher
HbA1c. Second, the results of additional analyses with
alteration of the definitions of potential confounders,
exploration of the presence of misclassification of albumin-
uria status, analyses with absolute versus percentage differ-
ences in retinal arteriolar diameter and skin perfusion, and
analyses with quintiles and deciles of flicker light-induced
retinal arteriolar dilation supported the robustness of our
results (Supplemental Results, http://links.lww.com/HJH/
A898).
DISCUSSION
This population-based study, in individuals without and
with type 2 diabetes, on the association of microvascular
endothelial dysfunction with albuminuria showed that
lower flicker light-induced retinal arteriolar dilation was
associated with albuminuria and that this association was
stronger in individuals with type 2 diabetes. In addition,
lower heat-induced skin hyperemia was associated with
albuminuria in participants with type 2 diabetes but not in
nondiabetic participants. These associations were indepen-
dent of CVD risk factors, including 24-h average ambulatory
blood pressure. To our knowledge, this is the first popula-
tion-based study that provides direct support for the con-
cept that microvascular endothelial dysfunction related to
albuminuria is extensive, if not generalized, and that this
association is stronger in individuals with than in those
without type 2 diabetes.
These results agree with those of studies in individuals
with type 1 or type 2 diabetes, which have shown associ-
ations of direct measures of microvascular endothelial
dysfunction in skin with albuminuria [17–19]. The present
study expands this knowledge, as it is the first to examine
microvascular endothelial dysfunction in two vascular beds
in a large, well characterized population-based sample of
individuals with and without type 2 diabetes, and with
extensive adjustment for potential confounders.
The association of microvascular endothelial dysfunc-
tion with albuminuria fits the hypothesis that albuminuria is
a biomarker of generalized endothelial dysfunction [6].
Endothelial dysfunction of the renal microcirculation may
cause albuminuria by increasing glomerular capillary wall
permeability and intraglomerular pressure [6]. The former
may involve alterations in the barrier properties of the
glomerular endothelium itself [6] and altered endothe-
lial–podocyte cross-talk leading to podocyte injury [31].
However, not all studies observed an association between
microvascular endothelial dysfunction and albuminuria.
For example, in a study in individuals with hypertension,
the endothelium-dependent vasodilatory response in the
forearm bed was not associated with albuminuria [32]. This
may be because of differences in participant selection (e.g.
hypertension versus diabetes).
The molecular mechanisms involved in both flicker
light-induced retinal arteriolar dilation and heat-induced
skin hyperemia include the endothelial release of nitric
oxide (NO) [22,23]. Reduced NO availability may reflect
microvascular endothelial dysfunction in general, but may
also play a direct role. Indeed, NO has been shown to
preserve glomerular capillary wall permeability [33], and
endothelial NO synthase inhibition induced podocyte
injury and albuminuria in an animal model of diabetes
[34]. In contrast, NO’s role in the regulation of renal hemo-
dynamics is unlikely to explain our results, because
reduced NO availability is expected to reduce rather than
increase intraglomerular pressure [35]. In addition to NO,
other substances secreted by the endothelium may be
involved in the association of microvascular endothelial
dysfunction and albuminuria.
The correlation between flicker light-induced retinal
arteriolar dilation and heat-induced skin hyperemia was
weak and not statistically significant. This may have several
explanations. First, both methods assess different vessel
types (i.e. relatively large arterioles in the retina versus small
arterioles, capillaries, and venules in skin) [36]. Second,
both methods assess different outcomes (i.e. a direct stim-
ulus-induced increase in vessel diameter in the retina versus
an indirect estimate of vasodilation by measuring stimulus-
induced increase in perfusion in skin) [22,23]. Third, both
methods use different stimuli to elicit the responses (i.e.
flicker light stimulation versus thermal stimulation) [22,23].
The results of this study suggest that hyperglycemia
amplifies the association of microvascular endothelial dys-
function with albuminuria. This observation is in agreement
with animal studies, which have shown higher UAE in
NO synthase knockout models in the presence of diabetes
[20,21]. In this regard, it has been suggested that hyper-
glycemia leads to dysregulation of the vascular endo-
thelial growth factor (VEGF)–NO axis [37]. That is, high
glucose levels may reduce NO availability and increase
VEGF expression [37]. In the face of reduced NO availabil-
ity, VEGF may exacerbate vascular injury through ab-
normal angiogenesis [37] and alteration of the endothelial
glycocalyx [38]. Alternatively, (hyperglycemia-induced)
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glomerular hyperfiltration [29,30] may increase permeation
of albumin through the injured glomerular capillary wall.
Although this hypothesis was not supported by a positive
interaction of microvascular endothelial dysfunction with
eGFR, the low precision of the eGFR equations at higher
GFR [28] may have masked this interaction.
Impaired neural activity is an additional mechanism that
can reduce both flicker light-induced retinal arteriolar dila-
tion and heat-induced skin hyperemia [22,23] and may as
well be involved in their association with albuminuria. For
example, autonomic dysfunction may compromise auto-
regulation of intraglomerular pressure and has indeed been
associated with albuminuria [39].
The association of flicker light-induced retinal arteriolar
dilation with albuminuria leveled off at lower levels. This
may be explained by selective nonparticipation of individ-
uals with higher UAE and the lowest flicker light-induced
retinal arteriolar dilation, who may suffer from the greatest
burden of comorbid disease, including impaired cognitive
performance and depression (i.e. incidence-prevalence
bias). In addition, the 95% CIs are too wide to exclude
the possibility that the true association is linear.
Baseline retinal arteriolar diameter was not associated
with albuminuria, whereas lower baseline skin perfusion
was associated with lower albuminuria. However, the pat-
tern of associations of baseline skin perfusion was not
consistent and not biologically plausible. Therefore, we
attribute these findings to the play of chance.
From a clinical perspective, microvascular endothelial
dysfunction may explain, at least in part, associations of
albuminuria with retinopathy, impaired cognitive perfor-
mance, depression, and heart failure [2,5,7,8]. In this regard,
the endothelial dysfunction observed in the retinal micro-
circulation of individuals with albuminuria may be particu-
larly relevant to its associations with impaired cognitive
performance and depression as well as retinopathy, as the
retinal and cerebral microcirculation show embryological,
anatomical, and physiological similarities [40]. In addition,
the skin microcirculation has been suggested to mirror the
systemic microcirculation [41,42].
The results of this study also suggest that albuminuria
may be a better biomarker of microvascular endothelial
dysfunction in individuals with than in those without type 2
diabetes. Therefore, associations of albuminuria with
microvascular disease may be stronger in type 2 diabetes.
To the best of our knowledge, there are no published data
on this issue.
An important strength of this study is the detailed char-
acterization of its population, which allowed for adjustment
for an extensive series of potential confounders. In partic-
ular, 24-h average ambulatory blood pressure may better
capture the effects of blood pressure on albuminuria than
office blood pressure, which reduces residual confounding.
In addition, an extensive series of additional analyses veri-
fied the robustness of our results.
The present study also had some limitations. First, the
cross-sectional design limited causal inferences. Second,
despite adjustment for an extensive series of potential
confounders, we cannot fully exclude residual confound-
ing. Conversely, the inclusion of variables, which could also
be intermediates in the association of microvascular
endothelial dysfunction with albuminuria in our models
may have introduced overadjustment bias [43]. For exam-
ple, higher blood pressure may be both a cause and a
consequence of endothelial dysfunction [44]. In addition,
adjustment for CVD and retinopathy might be considered
unnecessary as both may be manifestations of microvascu-
lar endothelial dysfunction [43]. Nevertheless, the regres-
sion coefficients were relatively robust to adjustment for the
variables in model 3a and the variables in the additional
analyses, which suggests that both residual confounding
and overadjustment bias are limited. Third, data on flicker
light-induced retinal arteriolar dilation and heat-induced
skin hyperemia were not available in all participants
(mainly because of logistic reasons [27]), and the retina
and skin study populations did not entirely overlap. How-
ever, the characteristics of included participants and par-
ticipants who were excluded because of missing data were
largely comparable, as were the characteristics of the par-
ticipants in the retina and skin study populations. Fourth,
actual glycaemia levels were not assessed at the day of
microvascular endothelial function assessment. Therefore,
acute effects of hyperglycemia could not be taken into
account. Fifth, the absolute number of participants
with albuminuria 15 to less than 30mg/24 h and at least
30mg/24 h in this population-based study was relatively
low. This may reduce statistical power, in particular for the
stratified analyses and the supplemental analyses with
albuminuria expressed as a categorical variable. Sixth,
the study population primarily consisted of Caucasian
individuals from European descent (98.9%), which poten-
tially limits its generalizability to other populations.
In conclusion, lower flicker light-induced retinal arteri-
olar dilation was independently associated with albumin-
uria and this association was stronger in individuals with
type 2 diabetes. In addition, lower heat-induced skin
hyperemia was independently associated with albuminuria
in individuals with type 2 diabetes. Thus, this is the first
population-based study that provides direct support for the
concept that microvascular endothelial dysfunction related
to albuminuria is extensive, if not generalized, and that this
association is stronger in individuals with than in those
without type 2 diabetes. This suggests that individuals with
albuminuria may not only benefit from improving renal
endothelial function and reducing albuminuria but also
from improving systemic endothelial function as well.
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Reviewers’ Summary Evaluations
Referee 1
A major strength of this paper deals with the demonstration
of an independent correlation between albuminuria and
microvascular endothelial dysfunction, particularly evident
in type 2 diabetes patients, a population with a number of
potential confounders. Weaknesses are the cross-sectional
design, which limits the causality of the associations, and the
vascular district explored. Indeed, although the skin micro-
circulation is a mirror of the systemic microcirculation, the
autocrine/paracrine property of the endothelium does not
allow considering a vascular district surrogate of another.
Referee 2
Microalbuminuria is considered not only a marker of renal
disease but also of generalized microvascular endothelial
function. For the latter there is, however, only limited direct
evidence available. In this paper microvascular endothelial
function has been assessed and relationships with micor-
albuminuria have been explored. The paper not only
shows that the proposed concept can be confirmed in
cross-sectional data but also reminds us that our methods
for assessment of both microalbuminuria and endothelial
function remain suboptimal.
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